Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal
Patent
1984-01-26
1987-08-04
Warren, Charles F.
Chemistry of carbon compounds
Miscellaneous organic carbon compounds
C-metal
2605005H, 564154, C09F 500, C09F 506
Patent
active
046844821
ABSTRACT:
Compounds are described of the general formula: ##STR1## wherein: R.sub.1 is acyl of the formula --C(.dbd.O)--R.sub.5 ; R.sub.2, R.sub.3, and R.sub.4 are each selected from the group consisting of hydrogen and acyl of the formula:
REFERENCES:
patent: 3118823 (1964-01-01), Gaeumann et al.
patent: 3153621 (1964-10-01), Gaeumann et al.
patent: 3247197 (1966-04-01), Gaeumann et al.
H. Bickel et al, "Metabolic Products of Microorganisms-XLIII-Information on Deferrioxamine B", Helv. Chem. Acta, vol. 46, No. 153, pp. 1385-1389 (1963).
H. Bickel, et al, Metabolic Products of Actinomycetaceane, XXVI, "Isolation and Properties of Ferrioxamines A to F, Representing New Sideramine Compounds", Helv. Chim. Acta, vol. 43, pp. 2118-2128 (1960).
H. Bickel et al, "XXVII, Constitutional Formulas of Ferrioxamine B", Helv. Chim. Acta, vol. 43, pp. 2129-2138 (1960).
V. Prelog and A. Walser, "Synthesis of Ferrioxamines B & D", Helv. Chim. Acta, vol. 45, pp. 631-637 (1962).
D. E. Green & T. B. Okarma, "Orally Effective Iron Chelators Related to Deferoxamine", Meeting Abstracts, 186th Annual Am. Chem. Soc. Mtg., Aug. 28-Sep. 2, 1983, Washington D.C., Abstr. No. MEDI 56.
D. J. Weatherall et al, Editorial Retrospective, "Iron Loading in Thalassemia-Fine Years with the Pump", New England Journal of Medicine, vol. 308, No. 8, pp. 456-457 (1983).
T. B. Okarma, "Development of an Orally Active Deferoxamine Derivative, V.A.M.C., Palo Alto, CA R.D.I.S.-Proj. Data Sheet, Oct. 1982.
T. B. Okarma, "Development of an Orally Effective Deferoxamine Derivative, V.A.M.C., Palo Alto, CA R.D.I.S.-Proj. Data Sheet, Nov. 18, 1983.
D. R. Crapper et al., "Aluminum and Other Metals in Senile (Alzheimer) Dementia", Aging, vol. 7, ed., R. Katzman et al., Black Raven Press, New York, New York, pp. 471-485 (1978).
J. R. McDermott, et al., "Brain Aluminum in Aging and Alzheimer Disease", Neurology, vol. 29, pp. 809-814 (1979).
S. H. Yalkowsky et al., Drug Design IX, Ariens, Ed., Academic Press, New York, 1980, pp. 167-179.
Y. Yamaoka, et al., "Low-Melting Phenyltoin Prodrugs as Alternative Oral Delivery Modes for Phenytoin: A Model for Other High-Melting Sparingly Water-Soluble Drugs", J. of Pharmaceutical Sciences, vol. 72, No. 4, pp. 400-405 (1983).
G. A. Trapp, et al., "Aluminum Levels in Brain in Alzheimer's Disease", Biological Psychiatry, vol. 13, No. 6, pp. 708-718 (1978).
D. R. Cropper, et al, "Aluminum, Neurofibrillary Degeneration and Alzheimer's Disease", Brain, vol. 99, pp. 67-80 (1976).
D. R. Cropper, et al., "Aluminum Induced Neurofibrillary Degeneration, Brain Electrical Activity and Alterations in Acquisition and Retention", Physiology and Behavior, vol. 10, pp. 935-945 (1973).
D. R. Cropper, et al., "Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration", Science, pp. 511-513 (Jul., 1973).
D. P. Perl, et al., "Alzheimer's Disease: X-ray Spectrometric Evidence of Aluminum Accumulation in Neurofibrillary Tangle-Bearing Neurons", Science, vol. 208, pp. 297-299 (Apr. 18, 1980).
A. C. Alfrey, et al., "The Dialysis Encephalopathy Syndrome", New England Journal of Medicine, vol. 294, No. 4, pp. 184-188 (Jan. 22, 1976).
Flaherty Elizabeth A.
Oral-D (L.P.)
Warren Charles F.
LandOfFree
Orally effective ion chelators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orally effective ion chelators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally effective ion chelators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-882908